Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2)

A Nardone; E Miller; on behalf of the ESEN2 group

doi:10.2807/esm.09.04.00456-en

Euroroundup Open Access

Like 0

This item has no PDF Download

Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2)
A Nardone¹ , E Miller¹ , on behalf of the ESEN2 group
View Affiliations Hide Affiliations

Affiliations: ¹ Health Protection Agency, CDSC, London, UK

Correspondence:
View Citation Hide Citation

Citation style for this article: Nardone A, Miller E, on behalf of the ESEN2 group. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Euro Surveill. 2004;9(4):pii=456. https://doi.org/10.2807/esm.09.04.00456-en

Abstract

Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.